drugset / Trial / NCT04335084

A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection

NCT04335084

Phase 2 Completed 254 enrolled ProgenaBiome DSCS CRO · collab
RandomizedSingle-groupDouble-blindPrevention

Summary

This is a Phase II interventional study testing whether treatment with hydroxychloroquine, Vitamin C, Vitamin D, and Zinc can prevent symptoms of COVID-19

Timeline

Start
2020-06-22
Primary completion
2022-05-31
Completion
2024-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule

Indications